Bioethics 28 (8):397-404 (2014)

Authors
Robert C. Hughes
University of Pennsylvania
Abstract
It is widely agreed that foreign sponsors of research in low- and middle-income countries (LMICs) are morally required to ensure that their research benefits the broader host community. There is no agreement, however, about how much benefit or what type of benefit research sponsors must provide, nor is there agreement about what group of people is entitled to benefit. To settle these questions, it is necessary to examine why research sponsors have an obligation to benefit the broader host community, not only their subjects. Justifying this claim is not straightforward. There are three justifications for an obligation to benefit host communities that each apply to some research, but not to all. Each requires a different amount of benefit, and each requires benefit to be directed toward a different group. If research involves significant net risk to LMIC subjects, research must provide adequate benefit to people in LMICs to avoid an unjustified appeal to subjects’ altruism. If research places significant burdens on public resources, research must provide fair compensation to the community whose public resources are burdened. If research is for profit, research sponsors must contribute adequately to the upkeep of public goods from which they benefit in order to avoid the wrong of free-riding, even if their use of these public goods is not burdensome.
Keywords international research  reasonable availability  community  fair benefits  exploitation
Categories (categorize this paper)
DOI 10.1111/bioe.12002
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 62,242
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

The Harm-Benefit Tradeoff in "Bad Deal" Trials.Gillian Nycum & Lynette Reid - 2007 - Kennedy Institute of Ethics Journal 17 (4):321-350.
Understanding Risks and Benefits in Research on Reproductive Genetic Technologies.Janet Malek - 2007 - Journal of Medicine and Philosophy 32 (4):339 – 358.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.

Analytics

Added to PP index
2012-10-02

Total views
43 ( #247,030 of 2,444,747 )

Recent downloads (6 months)
2 ( #311,178 of 2,444,747 )

How can I increase my downloads?

Downloads

My notes